These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794 [TBL] [Abstract][Full Text] [Related]
11. Advances in antiviral vaccine development. Graham BS Immunol Rev; 2013 Sep; 255(1):230-42. PubMed ID: 23947359 [TBL] [Abstract][Full Text] [Related]
12. Advances in the development of inactivated virus vaccines. Stauffer F; El-Bacha T; Da Poian AT Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):291-6. PubMed ID: 18221154 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated vaccines: Historical successes and current challenges. Minor PD Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107 [TBL] [Abstract][Full Text] [Related]
14. [What is the present status of the common virus vaccines?]. Regnard J Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188 [No Abstract] [Full Text] [Related]
16. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. Wu JJ; Huang DB; Pang KR; Tyring SK J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501 [TBL] [Abstract][Full Text] [Related]
17. The WHO programme for prevention and control of viral, chlamydial, and rickettsial diseases. Brief review. Assaad FA; Schild GC Arch Virol; 1983; 76(4):275-88. PubMed ID: 6194771 [TBL] [Abstract][Full Text] [Related]
18. Measles, mumps, rubella prevention: how can we do better? Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442 [TBL] [Abstract][Full Text] [Related]
19. Benefits, risks and costs of viral vaccines. Koplan JP; Axnick NW Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868 [No Abstract] [Full Text] [Related]
20. [The contribution of Pasteur Institute scientists to the development and study of the vaccine prevention of pediatric viral droplet infections]. Boĭchuk LM; Shikina ES; Smorodintsev AA Tr Inst Im Pastera; 1985; 62():26-34. PubMed ID: 2954271 [No Abstract] [Full Text] [Related] [Next] [New Search]